The first FDA-cleared medical device accessory for Apple Watch, KardiaBand can record an EKG in 30 seconds with just a touch of its integrated sensor. Results from the Kardia App are displayed on the face of Apple Watch. AliveCor is also introducing SmartRhythm uses artificial intelligence in concert with inputs from Apple Watch's heart rate and activity sensors.
It continuously evaluates the correlation between heart activity and physical activity. The device notifies users to capture an EKG with KardiaBand, or with KardiaMobile, AliveCor's popular, portable EKG reader, when heart rate and activity are in trouble. "KardiaBand paired with SmartRhythm technology will be life-changing for people who are serious about heart health," said Vic Gundotra, CEO, AliveCor. This will help doctors to identify serious conditions. Atrial Fibrillation (AFib), which affects more than 30 million people worldwide, is the most common heart arrhythmia and a leading cause of stroke. AliveCor uses advanced artificial intelligence, mobile, cloud and micro-electrode technology.
KardiaBand is available now for $199 and requires subscription to AliveCor's Premium service for $99 a year. The combined system includes SmartRhythm notifications on Apple Watch; unlimited EKG recordings; automatic detection of Atrial Fibrillation or normal sinus rhythm, the unlimited ability to send EKG readings to anyone via email. "Every week we receive incredible customer letters about how Apple Watch has affected their lives, including learning that they have AFib. These stories inspire us and we're determined to do more to help people understand their health," said Apple Chief Operating Officer Jeff Williams.Atrial fibrillation is responsible for 130,000 deaths a year in the U.S.